Eiken Chemical Co., Ltd.

2026/07/30 Updated
Market Cap: $504.2M (¥82.4B)
Stock Price: $15.29 (¥2,499)
Exchange Rate: 1 USD = ¥163.40

First Quarter Financial Results for Fiscal Year Ending March 2027 【Eiken Chemical】 Revenue of 1.07 billion yen, Net profit of 445 million yen

Eiken Chemical achieved revenue of 1.07 billion yen and net profit of 445 million yen in the first quarter of fiscal year ending March 2027. Revenue increased YoY, and net profit remained solid.

Importance:
Page Updated: July 30, 2026
IR Disclosure Date: July 30, 2026

Key Figures

  • Revenue: 1,072.8 million yen (YoY +5.2%)
  • Net profit: 445 million yen (YoY +25.8%)
  • Operating income: 667 million yen (YoY -16.7%)

AI要約

Performance Overview

In the first quarter of fiscal year ending March 2027, Eiken Chemical reported revenue of 1.07 billion yen (YoY +5.2%) and net profit of 445 million yen (YoY +25.8%). Strong sales in the pharmaceutical business and effective cost management significantly increased net profit. Although operating income declined, overall performance remains robust.

Future Outlook and Shareholder Impact

The company will continue expanding pharmaceutical sales and investing in research and development to sustain stable growth. Dividends are scheduled to be maintained at current levels, emphasizing shareholder returns. Ongoing focus on cash flow and cost control aims to enhance long-term corporate value.

Revenue Trend

Net Profit

Operating Income Trend

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Eiken Chemical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →